Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1991
03/19/1991US5001222 Des-17-histidine-calcitonin
03/19/1991US5001169 Inductive collagen-based bone repair preparations
03/19/1991US5001112 Antitumor antibiotic kedarcidin
03/19/1991US5001061 nifD promoter of Bradyrhizobium
03/19/1991US5001057 Truncated human IL-1 cDNA sequences which encode biologically-active human IL-1 proteins
03/19/1991US5001056 Linking proliferating cells and B-cells through antigens and surface immunoglobulins, fusing
03/19/1991US5001052 Immunoassay for FHAP and antibody useful therewith
03/19/1991US5001049 Method for determination of HIV specific antibodies
03/19/1991US5000953 Biologically active substance
03/19/1991US5000952 Polypeptide pertussis toxin vaccine
03/19/1991CA2025577A1 Anticoagulant and antihelminthic proteins and methods for the production and use of same
03/19/1991CA1281849C Solubilization of protein aggregates
03/19/1991CA1281671C Enhanced yeast transcription employing hybrid promoter region constructs
03/19/1991CA1281646C Recombinant interleukin-2 composition and process for making it
03/16/1991WO1991004327A1 Transgenic animal model for viral infections
03/16/1991WO1991004316A2 Ciliary neurotrophic factor
03/16/1991WO1991004262A1 New hcv isolates
03/16/1991CA2066614A1 Transgenic animal model for viral infections
03/16/1991CA2040404A1 Ciliary neurotrophic factor
03/16/1991CA2023936A1 Diol sulfonamide and sulfinyl renin inhibitors
03/15/1991WO1991004059A2 Method and useful apparatus for preparing pharmaceutical compositions
03/15/1991WO1991004050A1 Therapeutic compositions; methods for treatment of hiv infections
03/15/1991CA2067158A1 Method and useful apparatus for preparing pharmaceutical compositions
03/15/1991CA2065029A1 Therapeutic compositions; methods for treatment of hiv infections
03/14/1991CA2025230A1 Treponema hyodysenteriae antigens having a molecular weight of 39 kda and dna encoding therefor
03/13/1991WO1991004320A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man
03/13/1991EP0416983A1 Process for the preparation of a concentrate from factor VIII-factor von Willebrand of blood coagulation from the whole plasma
03/13/1991EP0416890A1 Method for activating protein C
03/13/1991EP0416740A2 Novel compounds with renin-inhibiting activity
03/13/1991EP0416725A2 Blood-borne non-A, non-B hepatitis specific protein, DNA encoding it, and process for its production
03/13/1991EP0416673A1 Method for the expression of heterologous proteins produced in fused form in E. coli, use thereof, expression vectors and recombinant strains
03/13/1991EP0416652A2 Interferon-gamma receptor fragment and its production
03/13/1991EP0416578A2 Protein, DNA and use thereof
03/13/1991EP0416505A2 Expression plasmids and use thereof
03/13/1991EP0416415A1 Process for upgrading of antimony halide catalyst solutions
03/13/1991EP0416393A1 Peptidyl difluorodiol renin inhibitors
03/13/1991EP0416373A2 Amino acid derivatives
03/13/1991EP0416033A1 Macrocyclic chelates and methods of use thereof.
03/13/1991EP0416032A1 Agrichemical screens
03/13/1991EP0416029A1 Procalcitonin peptides
03/13/1991EP0415999A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits
03/13/1991EP0415930A1 T cell activation markers
03/13/1991EP0415924A1 Regulation of cell proliferation and differentiation using peptides.
03/13/1991EP0415919A1 NEW TOXIN-ENCODING DNA FRAGMENTS FROM $i(BACILLUS) $i(THURINGIENSIS) SUBSP. $i(ISRAELENSIS)
03/13/1991EP0415909A1 A process and an agent for detection of gene structures in humans having a great tendency to develop iddm
03/13/1991EP0394326A4 Conformationally stabilized cell adhesion peptides
03/13/1991EP0379534A4 Method of purifying cross-linked hemoglobin
03/13/1991EP0185762B1 Cell-delivery agent
03/13/1991CA2065454A1 Use of thioredoxin in the treatment of malignantly transformed cells in animals and man
03/12/1991WO1991004267A1 A method for the purification of transforming growth factor (tgf-)
03/12/1991WO1991003551A1 Production of growth hormone in transgenic animal milk
03/12/1991WO1991003491A1 TGF-β PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION
03/12/1991US4999421 HTLV-I anti-sense RNA and encoded proteins
03/12/1991US4999370 Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system
03/12/1991US4999291 Production of human pluripotent granulocyte colony-stimulating factor
03/12/1991US4999192 Novel coleopteran-active bacillus thuringiensis isolate
03/12/1991CA2066576A1 Method and apparatus for the production of tgf-beta and purified tgf-beta compositions
03/12/1991CA2066228A1 Tgf-beta protein compositions for inhibition of cell proliferation
03/12/1991CA2065866A1 Production of growth hormone in transgenic animal milk
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/12/1991CA2024277A1 Screening methods for protease inhibitors
03/12/1991CA2023595A1 Chelating agents for forming complexes with radioactive isotopes, metal complexes thereof and use thereof in diagnosis and therapy
03/12/1991CA1281330C2 Intermediates for the preparation of n-alkylated dipeptides and their esters
03/09/1991WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas
03/09/1991WO1991003483A1 Tsh receptor
03/09/1991CA2024918A1 Fused proteins and production thereof
03/08/1991WO1991003555A1 Interleukin-4 receptors
03/08/1991WO1991003259A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
03/08/1991CA2066244A1 Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
03/08/1991CA2066240A1 Interleukin-4 receptors
03/08/1991CA2024782A1 High molecular weight protein/fatty acid condensation products which are very well tolerated by the skin and mucosa
03/08/1991CA2024697A1 Protein having anticoagulant properties
03/08/1991CA2005917A1 Method for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography
03/07/1991WO1991002978A1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids
03/07/1991WO1991002819A1 Recombinant japanese encephalitis molecules and methods of use therefor
03/07/1991WO1991002807A1 Production of biologically active insulin-like growth factor i from high expression host cell systems
03/07/1991WO1991002805A2 Recombinant retroviruses delivering vector constructs to target cells
03/07/1991WO1991002804A1 Recombinant adenovirus sequence expressing rhabdovirus antigen and use as a vaccine
03/07/1991WO1991002798A2 t-PA MUTANT GK1L
03/07/1991WO1991002797A1 Cell lineages infectable by a retrovirus and containing a marker activated by the infection
03/07/1991WO1991002796A1 Cystic fibrosis gene
03/07/1991WO1991002793A1 Cardiomyopathic transgenic non-human mammal
03/07/1991WO1991002792A1 Alkaline proteolytic enzyme and method of production
03/07/1991WO1991002756A1 Prohormone cleavage site blocking antibody
03/07/1991WO1991002754A1 Fusion proteins comprising gm-csf and il-3
03/07/1991WO1991002753A1 Anticoagulant protein
03/07/1991WO1991002751A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs
03/07/1991WO1991002749A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
03/07/1991WO1991002748A1 Rubella e1 peptides
03/07/1991WO1991002746A1 Therapeutic peptides
03/07/1991WO1991002735A1 Chemical compounds based on a netropsin or distamycin molecule coupled with an intercalating agent, method for preparing said compounds and pharmaceutical compositions containing same
03/07/1991WO1991002590A2 Immunoassay to detect pseudocercosporella antigen in cereal plants
03/07/1991WO1991002544A1 Composition containing a b epitope of the envelope glycoprotein of a retrovirus and a t epitope of a protein which is distinct from this virus
03/07/1991WO1991002540A1 Compositions for the inhibition of protein hormone formation and uses thereof
03/07/1991WO1991002539A1 Method of obtaining, from casein beta, biologically active peptide enriched fractions, and peptide fractions thus obtained
03/07/1991WO1991002537A1 Synthetic peptides that enhance cell binding
03/07/1991WO1991002536A1 Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders
03/07/1991CA2065017A1 Peptides from gtpase-activating protein (gap) and diagnostic and therapeutic use thereof
03/07/1991CA2064896A1 Therapeutic peptides
03/07/1991CA2039141A1 Composition resulting from the combination of the glycoprotein coat epitoque b of a type iv retrovirus and of an epitope t from a separate protein coded with this retrovirus, and their application for the production of protectors c antibodies for aids
1 ... 2773 2774 2775 2776 2777 2778 2779 2780 2781 2782 2783 2784 2785 2786 2787 2788 2789 2790 2791 2792 2793 ... 2916